Association of Smoothelin, a Cytoskeletal Component of Smooth Muscle Cells, With the Proliferative Features of Uterine Smooth Muscle Tumors
Pathology International · 2026-04 · 76 (4)
DOI: 10.1111/pin.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, online erschienen am 05.04.2026. Verfasst von Sayaka Shimodai-Yamada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Microbiology, Division of Human Pathology, Nihon University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Cytoskeletal Proteins, Muscle Proteins, Leiomyosarcoma, Uterine Neoplasms. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Smoothelin, a cytoskeletal protein expressed in smooth muscle cells (SMCs), colocalizes with α‐smooth muscle actin and is typically restricted to the cytoplasm. Interestingly, in malignant smooth muscle tumors (SMTs), particularly uterine leiomyosarcoma (LMS), aberrant nuclear localization of smoothelin has been observed, though the underlying mechanism remains unclear. To investigate, 99 uterine SMT cases were analyzed, comprising 26 LMS and 73 non‐LMS (typical leiomyoma, cellular leiomyoma, mitotically active leiomyoma, and tumors of uncertain malignant potential). Histopathological and immunohistochemical evaluations included mitotic activity, Ki‐67 index, and smoothelin expression. In vitro, two humans uterine LMS cell lines (SK‐LMS‐1, SK‐UT‐1) and a primary uterine SMC line under proliferative conditions were examined. Nuclear smoothelin expression was significantly more frequent in LMS compared with non‐LMS. Within LMS tissues, both cytoplasmic and nuclear positivity were noted. Smoothelin‐positive regions exhibited significantly higher mitotic activity, whereas Ki‐67 labeling and nuclear size variation showed no association with localization. In cultured LMS cells, proliferation correlated with increased nuclear smoothelin positivity. These findings suggest that smoothelin is linked to proliferative capacity in SMTs, and its altered subcellular distribution may have potential utility in the pathological evaluation of SMTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Microbiology, Division of Human Pathology, Nihon University School of Medicine, Tokyo, Japan.
- Department of Molecular Genetics, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
- Department of Pediatric Surgery, Nihon University School of Medicine, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan.
ORCID-Profile: Sayaka Shimodai-Yamada, Kenta Uto
Zitieren
APA
Shimodai-Yamada, S., Uto, K., Eys, G. V., Denda, Y., Suzuki, M., Kawana, K., & Hao, H. (2026). Association of Smoothelin, a Cytoskeletal Component of Smooth Muscle Cells, With the Proliferative Features of Uterine Smooth Muscle Tumors. Pathology International, 76(4). https://doi.org/10.1111/pin.70110
Vancouver
Shimodai-Yamada S, Uto K, Eys GV, Denda Y, Suzuki M, Kawana K, et al. Association of Smoothelin, a Cytoskeletal Component of Smooth Muscle Cells, With the Proliferative Features of Uterine Smooth Muscle Tumors. Pathology International. 2026;76(4). doi:10.1111/pin.70110
BibTeX
@article{ShimodaiYamada2026,
author = {Shimodai-Yamada, Sayaka and Uto, Kenta and Eys, Guillaume van and Denda, Yuya and Suzuki, Mayumi and Kawana, Kei and Hao, Hiroyuki},
title = {Association of Smoothelin, a Cytoskeletal Component of Smooth Muscle Cells, With the Proliferative Features of Uterine Smooth Muscle Tumors},
journal = {Pathology International},
year = {2026},
volume = {76},
number = {4},
doi = {10.1111/pin.70110}
}
EUVIMED